Electromed, Inc.ELMDNYSE
Loading
Year-over-year research & development expense growth
5Y CAGR
-8.3%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 51.83% |
| 2024 | -28.38% |
| 2023 | -32.45% |
| 2022 | -21.25% |
| 2021 | 64.00% |
| 2020 | 80.01% |
| 2019 | 131.99% |
| 2018 | -57.87% |
| 2017 | 56.91% |
| 2016 | 20.51% |